vs
Side-by-side financial comparison of Equity Residential (EQR) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
Equity Residential is the larger business by last-quarter revenue ($781.9M vs $493.8M, roughly 1.6× Pediatrix Medical Group, Inc.). Equity Residential runs the higher net margin — 48.9% vs 6.8%, a 42.0% gap on every dollar of revenue. On growth, Equity Residential posted the faster year-over-year revenue change (2.0% vs -1.7%). Over the past eight quarters, Equity Residential's revenue compounded faster (3.4% CAGR vs -0.1%).
Equity Residential is a United States–based publicly traded real estate investment trust that invests in apartments.
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
EQR vs MD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $781.9M | $493.8M |
| Net Profit | $382.1M | $33.7M |
| Gross Margin | — | — |
| Operating Margin | 50.6% | 9.9% |
| Net Margin | 48.9% | 6.8% |
| Revenue YoY | 2.0% | -1.7% |
| Net Profit YoY | -8.8% | 10.5% |
| EPS (diluted) | $1.01 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $781.9M | $493.8M | ||
| Q3 25 | $782.4M | $492.9M | ||
| Q2 25 | $768.8M | $468.8M | ||
| Q1 25 | $760.8M | $458.4M | ||
| Q4 24 | $766.8M | $502.4M | ||
| Q3 24 | $748.3M | $511.2M | ||
| Q2 24 | $734.2M | $504.3M | ||
| Q1 24 | $730.8M | $495.1M |
| Q4 25 | $382.1M | $33.7M | ||
| Q3 25 | $289.1M | $71.7M | ||
| Q2 25 | $192.4M | $39.3M | ||
| Q1 25 | $256.6M | $20.7M | ||
| Q4 24 | $419.1M | $30.5M | ||
| Q3 24 | $143.4M | $19.4M | ||
| Q2 24 | $177.5M | $-153.0M | ||
| Q1 24 | $295.8M | $4.0M |
| Q4 25 | 50.6% | 9.9% | ||
| Q3 25 | 38.5% | 13.8% | ||
| Q2 25 | 26.6% | 12.8% | ||
| Q1 25 | 35.7% | 7.0% | ||
| Q4 24 | 57.2% | 7.8% | ||
| Q3 24 | 20.1% | 6.6% | ||
| Q2 24 | 25.3% | -31.3% | ||
| Q1 24 | 42.0% | 3.2% |
| Q4 25 | 48.9% | 6.8% | ||
| Q3 25 | 36.9% | 14.5% | ||
| Q2 25 | 25.0% | 8.4% | ||
| Q1 25 | 33.7% | 4.5% | ||
| Q4 24 | 54.7% | 6.1% | ||
| Q3 24 | 19.2% | 3.8% | ||
| Q2 24 | 24.2% | -30.3% | ||
| Q1 24 | 40.5% | 0.8% |
| Q4 25 | $1.01 | $0.40 | ||
| Q3 25 | $0.76 | $0.84 | ||
| Q2 25 | $0.50 | $0.46 | ||
| Q1 25 | $0.67 | $0.24 | ||
| Q4 24 | $1.10 | $0.37 | ||
| Q3 24 | $0.38 | $0.23 | ||
| Q2 24 | $0.47 | $-1.84 | ||
| Q1 24 | $0.77 | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $55.9M | $375.2M |
| Total DebtLower is stronger | $8.2B | $570.5M |
| Stockholders' EquityBook value | $11.0B | $865.9M |
| Total Assets | $20.7B | $2.2B |
| Debt / EquityLower = less leverage | 0.75× | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $55.9M | $375.2M | ||
| Q3 25 | $93.1M | $340.1M | ||
| Q2 25 | $31.3M | $224.7M | ||
| Q1 25 | $39.8M | $99.0M | ||
| Q4 24 | $62.3M | $229.9M | ||
| Q3 24 | $28.6M | $103.8M | ||
| Q2 24 | $38.3M | $19.4M | ||
| Q1 24 | $44.5M | $8.0M |
| Q4 25 | $8.2B | $570.5M | ||
| Q3 25 | — | $577.2M | ||
| Q2 25 | — | $583.9M | ||
| Q1 25 | — | $590.5M | ||
| Q4 24 | $8.2B | $597.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $11.0B | $865.9M | ||
| Q3 25 | $11.1B | $890.7M | ||
| Q2 25 | $11.0B | $833.8M | ||
| Q1 25 | $11.0B | $789.2M | ||
| Q4 24 | $11.0B | $764.9M | ||
| Q3 24 | $10.9B | $732.5M | ||
| Q2 24 | $11.0B | $706.5M | ||
| Q1 24 | $11.1B | $856.2M |
| Q4 25 | $20.7B | $2.2B | ||
| Q3 25 | $21.1B | $2.2B | ||
| Q2 25 | $21.0B | $2.1B | ||
| Q1 25 | $20.6B | $2.0B | ||
| Q4 24 | $20.8B | $2.2B | ||
| Q3 24 | $20.9B | $2.1B | ||
| Q2 24 | $19.8B | $2.0B | ||
| Q1 24 | $19.9B | $2.2B |
| Q4 25 | 0.75× | 0.66× | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | — | 0.70× | ||
| Q1 25 | — | 0.75× | ||
| Q4 24 | 0.74× | 0.78× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $387.0M | $114.1M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 1.01× | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $387.0M | $114.1M | ||
| Q3 25 | $476.7M | $137.3M | ||
| Q2 25 | $359.5M | $137.2M | ||
| Q1 25 | $425.5M | $-117.5M | ||
| Q4 24 | $354.2M | $133.0M | ||
| Q3 24 | $401.4M | $91.8M | ||
| Q2 24 | $396.9M | $107.0M | ||
| Q1 24 | $421.0M | $-125.2M |
| Q4 25 | 1.01× | 3.39× | ||
| Q3 25 | 1.65× | 1.91× | ||
| Q2 25 | 1.87× | 3.49× | ||
| Q1 25 | 1.66× | -5.66× | ||
| Q4 24 | 0.85× | 4.36× | ||
| Q3 24 | 2.80× | 4.72× | ||
| Q2 24 | 2.24× | — | ||
| Q1 24 | 1.42× | -31.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EQR
Segment breakdown not available.
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
